ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04621	NOD-like receptor signaling pathway	7/40	157/7206	2.07683316087e-05
ko04668	TNF signaling pathway	6/40	120/7206	4.54629021828e-05
ko05160	Hepatitis C	6/40	153/7206	0.000175548676
ko05100	Bacterial invasion of epithelial cells	5/40	99/7206	0.000198754334023
ko04620	Toll-like receptor signaling pathway	5/40	100/7206	0.000208368007682
ko04217	Necroptosis	6/40	178/7206	0.000398699418117
ko04810	Regulation of actin cytoskeleton	7/40	264/7206	0.000540299201763
ko01522	Endocrine resistance	5/40	124/7206	0.000565326690478
ko04072	Phospholipase D signaling pathway	6/40	197/7206	0.000683732964784
ko05131	Shigellosis	4/40	82/7206	0.00104247435838
ko05212	Pancreatic cancer	4/40	83/7206	0.00109089864234
ko04064	NF-kappa B signaling pathway	4/40	96/7206	0.00187248560674
ko01521	EGFR tyrosine kinase inhibitor resistance	4/40	106/7206	0.00269080250085
ko05152	Tuberculosis	5/40	187/7206	0.00351186817091
ko05167	Kaposi's sarcoma-associated herpesvirus infection	5/40	191/7206	0.00384551979
ko05162	Measles	4/40	120/7206	0.00420841677929
ko04666	Fc gamma R-mediated phagocytosis	4/40	122/7206	0.00446418340311
ko05213	Endometrial cancer	3/40	62/7206	0.0047781784629
ko04622	RIG-I-like receptor signaling pathway	3/40	62/7206	0.0047781784629
ko05200	Pathways in cancer	8/40	492/7206	0.00490797606874
ko05223	Non-small cell lung cancer	3/40	66/7206	0.00569357727991
ko04380	Osteoclast differentiation	4/40	134/7206	0.00622239628891
ko04933	AGE-RAGE signaling pathway in diabetic complications	4/40	135/7206	0.00638697188649
ko04214	Apoptosis - fly	3/40	72/7206	0.0072524188869
ko04919	Thyroid hormone signaling pathway	4/40	143/7206	0.00780919920246
ko01524	Platinum drug resistance	3/40	76/7206	0.00841919017267
ko05214	Glioma	3/40	79/7206	0.00936281637402
ko05230	Central carbon metabolism in cancer	3/40	81/7206	0.0100250034671
ko05218	Melanoma	3/40	85/7206	0.0114298081508
ko05210	Colorectal cancer	3/40	86/7206	0.0117979101532
ko04662	B cell receptor signaling pathway	3/40	88/7206	0.0125545529397
ko04320	Dorso-ventral axis formation	2/40	31/7206	0.0126210178161
ko00562	Inositol phosphate metabolism	3/40	89/7206	0.0129431349417
ko05161	Hepatitis B	4/40	173/7206	0.0149625407822
ko05224	Breast cancer	4/40	174/7206	0.0152540949818
ko04218	Cellular senescence	4/40	177/7206	0.0161503913304
ko04210	Apoptosis	4/40	180/7206	0.0170794295497
ko05146	Amoebiasis	3/40	99/7206	0.0172093189645
ko05168	Herpes simplex infection	4/40	182/7206	0.0177171568141
ko04015	Rap1 signaling pathway	5/40	278/7206	0.0179641673988
ko00524	Neomycin, kanamycin and gentamicin biosynthesis	1/40	4/7206	0.0220240722518
ko04012	ErbB signaling pathway	3/40	109/7206	0.0221757399981
ko04973	Carbohydrate digestion and absorption	2/40	42/7206	0.0224912502161
ko05215	Prostate cancer	3/40	111/7206	0.0232537297578
ko04070	Phosphatidylinositol signaling system	3/40	112/7206	0.023803334259
ko04013	MAPK signaling pathway - fly	3/40	115/7206	0.0254945915857
ko05169	Epstein-Barr virus infection	4/40	206/7206	0.0265512983988
ko04215	Apoptosis - multiple species	2/40	47/7206	0.0277522639914
ko05219	Bladder cancer	2/40	48/7206	0.028858644523
ko04750	Inflammatory mediator regulation of TRP channels	3/40	122/7206	0.0296882256522
ko04624	Toll and Imd signaling pathway	2/40	49/7206	0.0299825666051
ko04066	HIF-1 signaling pathway	3/40	123/7206	0.0303155330557
ko04660	T cell receptor signaling pathway	3/40	124/7206	0.0309498780993
ko05142	Chagas disease (American trypanosomiasis)	3/40	130/7206	0.0349033058893
ko04915	Estrogen signaling pathway	3/40	131/7206	0.0355866861485
ko04930	Type II diabetes mellitus	2/40	54/7206	0.0358577223973
ko05231	Choline metabolism in cancer	3/40	134/7206	0.0376785753838
ko05321	Inflammatory bowel disease (IBD)	2/40	56/7206	0.0383230713518
ko04144	Endocytosis	5/40	342/7206	0.0393734090144
ko04961	Endocrine and other factor-regulated calcium reabsorption	2/40	59/7206	0.0421394206622
ko00521	Streptomycin biosynthesis	1/40	8/7206	0.0435749502382
ko05221	Acute myeloid leukemia	2/40	63/7206	0.0474402812939